A Study of PF-06873600 in People With Cancer

Clinical trial NCT03519178 · TERMINATED

Trial details

NCT number: NCT03519178
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer

Start date: 2018-03-07
Primary completion: 2023-04-05
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.